Arkolith/Insider Trading/NIKA/Form 4

Savov Dimitar Slavchev

CEO, CFO, President, Director, 10% OwnerNIKA PHARMACEUTICALS, INC (NIKA) · full profile →Form 4 · filed Mar 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$500K
Net Open-Market Flow
-$500K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2025Sell(S)2.0M$0.25$500K455.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001826466-25-000024) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML